<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html xmlns:o="urn:schemas-microsoft-com:office:office" __expr-val-dir="ltr" dir="ltr"><head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
<meta name="GENERATOR" content="Microsoft SharePoint"/><meta name="progid" content="SharePoint.WebPartPage.Document"/><meta http-equiv="Expires" content="0"/><title>
	Proposed Revision | APA DSM-5
</title><link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/HtmlEditorCustomStyles.css"/>
<link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/HtmlEditorTableFormats.css"/>
<link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/core.css"/>
<link rel="stylesheet" type="text/css" href="../../Style Library/DSM_Css/DSM.css"/>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/init.js"></script>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/core.js" defer></script>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/non_ie.js"></script>
<link type="text/xml" rel="alternate" href="http://www.dsm5.org/proposedrevision/_vti_bin/spsdisco.aspx"/>
	<style type="text/css">
		#DSM_MainContent {
			background-color: transparent;
			padding: 0px;
		}			
	</style>
<!--[if gte mso 9]><xml>
<o:CustomDocumentProperties>
<o:PublishingContactPicture msdt:dt="string" dt="string">, </o:PublishingContactPicture></o:CustomDocumentProperties></xml><![endif]-->
<script type="text/javascript" src="../../_layouts/Emagination.jQuery/jquery-1.3.2.min.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery/jquery.easing.1.3.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery.SPServices/jquery.SPServices-0.5.7.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery.SPServices/jquery.SPServices-0.5.7.min.js"></script><script language="javascript" src="../../Style Library/DSM_js/RevisionTabs.js" type="text/javascript"></script><script language="javascript" src="../../Style Library/DSM_js/search.js" type="text/javascript"></script></head><body style="background:url(../../Style%20Library/DSM_Images/background.gif) repeat-x;margin:0px;" scroll="yes" onload="javascript:if (typeof(_spBodyOnLoadWrapper) != 'undefined') _spBodyOnLoadWrapper();"><form name="aspnetForm" method="post" action="../../ProposedRevision/Pages/proposedrevision_rid_196.html" id="aspnetForm">
<input type="hidden" name="MSO_PageHashCode" id="MSO_PageHashCode" value="5295-48993826"/>
<input type="hidden" name="__SPSCEditMenu" id="__SPSCEditMenu" value="true"/>
<input type="hidden" name="MSOWebPartPage_PostbackSource" id="MSOWebPartPage_PostbackSource" value=""/>
<input type="hidden" name="MSOTlPn_SelectedWpId" id="MSOTlPn_SelectedWpId" value=""/>
<input type="hidden" name="MSOTlPn_View" id="MSOTlPn_View" value="0"/>
<input type="hidden" name="MSOTlPn_ShowSettings" id="MSOTlPn_ShowSettings" value="False"/>
<input type="hidden" name="MSOGallery_SelectedLibrary" id="MSOGallery_SelectedLibrary" value=""/>
<input type="hidden" name="MSOGallery_FilterString" id="MSOGallery_FilterString" value=""/>
<input type="hidden" name="MSOTlPn_Button" id="MSOTlPn_Button" value="none"/>
<input type="hidden" name="__REQUESTDIGEST" id="__REQUESTDIGEST" value="0xCE66FF9FFDC4C427EA024444B0B3FDFE0422B64557A1F0FB3BDDA36BF90A1C780D84EA3A5FC65B412200A17A5EF4D3612906145B5239FCE5436838BD9D975D81,22 Oct 2012 21:28:41 -0000"/>
<input type="hidden" name="MSOAuthoringConsole_FormContext" id="MSOAuthoringConsole_FormContext" value=""/>
<input type="hidden" name="MSOAC_EditDuringWorkflow" id="MSOAC_EditDuringWorkflow" value=""/>
<input type="hidden" name="MSOSPWebPartManager_DisplayModeName" id="MSOSPWebPartManager_DisplayModeName" value="Browse"/>
<input type="hidden" name="MSOWebPartPage_Shared" id="MSOWebPartPage_Shared" value=""/>
<input type="hidden" name="MSOLayout_LayoutChanges" id="MSOLayout_LayoutChanges" value=""/>
<input type="hidden" name="MSOLayout_InDesignMode" id="MSOLayout_InDesignMode" value=""/>
<input type="hidden" name="MSOSPWebPartManager_OldDisplayModeName" id="MSOSPWebPartManager_OldDisplayModeName" value="Browse"/>
<input type="hidden" name="MSOSPWebPartManager_StartWebPartEditingName" id="MSOSPWebPartManager_StartWebPartEditingName" value="false"/>
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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"/>
<script> var MSOWebPartPageFormName = 'aspnetForm';</script>
<script type="text/javascript">
//<![CDATA[
                function DoCallBack(filterText)
                {
                    WebForm_DoCallback('ctl00$m$g_df258af6_3061_4b80_a680_48204ee9cef4',filterText,UpdateFilterCallback,0,CallBackError,true);
                }
                function CallBackError(result, clientsideString)
                {                
                }
var globalArg_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71;
var globalContext_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71;
function ExpGroupCallServerg_3cf5e074_39b0_425f_92e8_f3c760a6ce71(arg, context)
{
    globalArg_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71 = "GroupString=" + arg + "&ConnectionFilterString=";
    globalContext_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71 = context;
    setTimeout("WebForm_DoCallback('ctl00$m$g_3cf5e074_39b0_425f_92e8_f3c760a6ce71',globalArg_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71,ExpGroupReceiveData,globalContext_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71,ExpGroupOnError,true)", 0);
}
function ExpGroupOnError(message, context) {
alert('An error has occurred with the data fetch.  Please refresh the page and retry.');
}
if (typeof(_spBodyOnLoadFunctionNames) != "undefined") {
if (_spBodyOnLoadFunctionNames != null) {
_spBodyOnLoadFunctionNames.push("ExpGroupOnPageLoad");
}
}//]]>
</script>
<script src="../../WebResource.axd_d_T_sWwmChWv5_0o-vuzl71g2_t_633965588901821931.js" type="text/javascript"></script>
<!-- begin MAIN LAYOUT -->
		<div id="DSM_MainContainer">
			<div id="DSM_Header">	
	<!---- begin ACCESSIBILITY FEATURE ---->
					<div id="TurnOnAccessibility" style="display:none">
			   		<a href="#" class="ms-skip" onclick="SetIsAccessibilityFeatureEnabled(true);UpdateAccessibilityUI();return false;">
					Turn on more accessible mode</a></div>
					<a href="javascript:;" onclick="javascript:this.href='#mainContent';" class="ms-skip" accesskey="J">
					Skip to main content</a>
			  		<div id="TurnOffAccessibility" style="display:none">
					<a href="#" class="ms-acclink" onclick="SetIsAccessibilityFeatureEnabled(false);UpdateAccessibilityUI();return false;">
					Turn off more accessible mode</a></div>
	<!---- end ACCESSIBILITY FEATURE ---->
	<!-- begin UPPER BAR for SITE ACTIONS and EDITING ELEMENTS -->
	<div id="SP_adminBar">
		<tr><td colspan="4" id="mpdmconsole" class="ms-consolemptablerow">
<!-- Console -->
<span id="ctl00_SPNavigation_ctl01_publishingContext1"></span>
<!-- Console -->
</td></tr>
	</div>
<!-- end UPPER BAR for SITE ACTIONS and EDITING ELEMENTS -->
				<h1><a href="/">American Psychiatric Association DSM-5 Development</a></h1>	
				<div id="DSM_UtilityLinks"><a href="http://www.psychiatry.org/">www.psychiatry.org</a></div>
				<!--<div id="DSM_UtilityLinks3"><a href="/pages/registration.aspx">Volunteer for Field Trials</a></div>-->
				<div id="DSM_UtilityLinks2"><a href="../../Pages/TermsandConditionsofUse.html">Terms and Conditions of Use</a></div>
				<div id="DSM_SearchForm">
					<table>
						<tr>
							<td><input type="text" id="searchTerm" onkeydown="searchSubmitEnter()"/></td>
							<td><img src="../../Style Library/DSM_Images/search.gif" alt="Search" id="searchBtn" onclick="searchSubmitClick()"/></td>
						</tr>
					</table>					
				</div>			
			</div>	
			<div id="DSM_TopNavBar">
<!---- begin TOP NAVIGATION ---->		
			<table id="zz1_TopNavigationMenu" class="ms-topNavContainer" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td onmouseover="Menu_HoverRoot(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun0"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
			<tr>
				<td><a class="DSM_staticNavItem" href="/" accesskey="1">Home</a></td>
			</tr>
		</table></td><td width="0"></td><td><table border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="About DSM-5" id="zz1_TopNavigationMenun1"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../about/Pages/Default.html">About DSM-5</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Meet Us" id="zz1_TopNavigationMenun2"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../MeetUs/Pages/Default.html">Meet Us</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Research Background" id="zz1_TopNavigationMenun3"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../Research/Pages/Default.html">Research Background</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="General Resources" id="zz1_TopNavigationMenun4"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../ProgressReports/Pages/Default.html">General Resources</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="DSM-5 Proposed Revisions" id="zz1_TopNavigationMenun5"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../proposedrevision/Pages/Default.html">Proposed Revisions</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Newsroom" id="zz1_TopNavigationMenun6"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../Newsroom/Pages/Default.html">Newsroom</a></td>
					</tr>
				</table></td><td width="0"></td>
			</tr>
		</table><div id="zz1_TopNavigationMenun1Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="DSM-V Overview" id="zz1_TopNavigationMenun7">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/DSMVOverview.html">DSM-5 Overview: The Future Manual</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Timeline" id="zz1_TopNavigationMenun8">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/Timeline.html">Timeline</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Board of Trustee Principles" id="zz1_TopNavigationMenun9">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/BoardofTrusteePrinciples.html">Board of Trustee Principles</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Frequently Asked Questions" id="zz1_TopNavigationMenun10">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/faq.html">Frequently Asked Questions</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun1ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun1ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun2Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Task Force Members" id="zz1_TopNavigationMenun11">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../MeetUs/Pages/TaskForceMembers.html">Task Force Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Study Group Members" id="zz1_TopNavigationMenun12">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../MeetUs/Pages/StudyGroupMembers.html">Study Group Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Work Group Members" id="zz1_TopNavigationMenun13">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../MeetUs/Pages/WorkGroupMembers.html">Work Group Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun14">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/BoardofTrusteePrinciples.html">Board of Trustee Principles</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun2ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun2ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun3Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun15">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/ConferenceSummariesandMonographs.html">DSM-5 Research Planning Conference Summaries and Monographs</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun16">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/Presentations.html">Presentations on DSM-5 and Related Topics</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun17">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/Publications.html">Publications from DSM-5 Development</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun18">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/DSM-5FieldTrials.html">DSM-5 Field Trials</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun3ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun3ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun5Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Neurodevelopmental Disorders" id="zz1_TopNavigationMenun19">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/NeurodevelopmentalDisorders.html">Neurodevelopmental Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Schizophrenia Spectrum and Other Psychotic Disorders" id="zz1_TopNavigationMenun20">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SchizophreniaSpectrumandOtherPsychoticDisorders.html">Schizophrenia Spectrum and Other Psychotic Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Bipolar and Related Disorders" id="zz1_TopNavigationMenun21">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/BipolarandRelatedDisorders.html">Bipolar and Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Depressive Disorders" id="zz1_TopNavigationMenun22">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/DepressiveDisorders.html">Depressive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Anxiety Disorders" id="zz1_TopNavigationMenun23">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/AnxietyDisorders.html">Anxiety Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Obsessive-Compulsive and Related Disorders" id="zz1_TopNavigationMenun24">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Obsessive-CompulsiveandRelatedDisorders.html">Obsessive-Compulsive and Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Trauma and Stressor Related Disorders" id="zz1_TopNavigationMenun25">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/TraumaandStressorRelatedDisorders.html">Trauma- and Stressor-Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Dissociative Disorders" id="zz1_TopNavigationMenun26">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/DissociativeDisorders.html">Dissociative Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Somatic Symptom Disorders" id="zz1_TopNavigationMenun27">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SomaticSymptomDisorders.html">Somatic Symptom Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Feeding and Eating Disorders" id="zz1_TopNavigationMenun28">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/FeedingandEatingDisorders.html">Feeding and Eating Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Elimination Disorders" id="zz1_TopNavigationMenun29">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/EliminationDisorders.html">Elimination Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Sleep-Wake Disorders" id="zz1_TopNavigationMenun30">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Sleep-WakeDisorders.html">Sleep-Wake Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Sexual Dysfunctions" id="zz1_TopNavigationMenun31">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SexualDysfunctions.html">Sexual Dysfunctions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Gender Dysphoria" id="zz1_TopNavigationMenun32">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/GenderDysphoria.html">Gender Dysphoria</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Disruptive, Impulse Control, and Conduct Disorders" id="zz1_TopNavigationMenun33">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Disruptive_ImpulseControl_andConductDisorders.html">Disruptive, Impulse Control, and Conduct Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Substance Use and Addictive Disorders" id="zz1_TopNavigationMenun34">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SubstanceUseandAddictiveDisorders.html">Substance Use and Addictive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Neurocognitive Disorders" id="zz1_TopNavigationMenun35">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/NeurocognitiveDisorders.html">Neurocognitive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Personality Disorders" id="zz1_TopNavigationMenun36">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/PersonalityDisorders.html">Personality Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Paraphilic Disorders" id="zz1_TopNavigationMenun37">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/ParaphilicDisorders.html">Paraphilic Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Other Disorders" id="zz1_TopNavigationMenun38">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/OtherDisorders.html">Other Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Proposed DSM-5 Organizational Structure and Disorder Names" id="zz1_TopNavigationMenun39">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/proposed-dsm5-organizational-structure-and-disorder-names.html">Proposed DSM-5 Organizational Structure and Disorder Names</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Proposed Mental Disorder Definitions" id="zz1_TopNavigationMenun40">
					<td><table class="DSM_dynamicNavSelected DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavSelected DSM_dynamicNavItem" href="../../proposedrevision/Pages/proposedrevision_rid_465.html">Proposed Mental Disorder Definitions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun41">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Cult.html">DSM-5 Cultural Formulation Interview</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun5ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun5ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun6Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun42">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Newsroom/Pages/PressReleases.html">Press Releases</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun43">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Newsroom/Pages/MediaContact.html">Media Contact</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="FAQ" id="zz1_TopNavigationMenun44">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/faq.html">Frequently Asked Questions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun45">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Newsroom/Pages/Commentaries.html">Commentaries, Responses, and Other DSM-5 News </a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun6ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun6ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div></td>
	</tr>
</table>
<!---- end TOP NAVIGATION ---->
		</div>
			<div id="DSM_MainContent">
<!---- begin MAIN CONTENT AREA ---->
		<a name="mainContent"></a>
	<div id="DSM_LeftCol">												
		<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ1" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="df258af6-3061-4b80-a680-48204ee9cef4" haspers="false" id="WebPartWPQ1" width="100%" allowdelete="false" style=""><div id="DSM_Breadcrumbs" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><script>top.document.title ="APA DSM-5 |  M 02 Narcolepsy/Hypocretin Deficiency "</script><span><a class="DSM_bcNode" href="/">Home</a></span><span class="DSM_bcSeparator"> / </span><span><a class="DSM_bcNode" title="Proposed Revisions" href="../../proposedrevision/Pages/Default.html">
				Proposed Revisions
			</a></span><span class="DSM_bcSeparator"> / </span><span class="DSM_bcNode"><a target="_self" href="../../proposedrevision/Pages/Sleep-WakeDisorders.html">Sleep-Wake Disorders</a></span><span class="DSM_bcSeparator"> / </span><span class="DSM_bcNode"></span><span class="DSM_bcSeparator"> / </span><span class="DSM_bcCurrent"> M 02 Narcolepsy/Hypocretin Deficiency </span></div><table cellspacing="0" cellpadding="4" border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr></tr></table></div></td>
			</tr>
		</table><div class="ms-PartSpacingVertical"></div></td>
	</tr><tr>
		<td id="MSOZoneCell_WebPartWPQ2" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="c31544f0-05e5-4027-985a-b5882502a9eb" haspers="false" id="WebPartWPQ2" width="100%" allowdelete="false" style=""><table border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr><td><table border="0" cellspacing="0" width="100%"><tr><td><h1><span><br>M 02 Narcolepsy/Hypocretin Deficiency </span></h1><div class="DSM_TabBar"><ul><li><a href="#" id="DSM_Tab_Proposed" class="DSM_TabOn" onclick="TabClick('Proposed','Rationale','Severity','DSM-IV')">Proposed   
								&nbsp;Revision</a></li><li><a href="#" id="DSM_Tab_Rationale" class="DSM_TabOff" onclick="TabClick('Rationale','Proposed','Severity','DSM-IV')">Rationale</a></li><li><a href="#" id="DSM_Tab_Severity" class="DSM_TabOff" onclick="TabClick('Severity','Proposed','Rationale','DSM-IV')">Severity</a></li><li><a href="#" id="DSM_Tab_DSM-IV" class="DSM_TabOff" onclick="TabClick('DSM-IV','Proposed','Rationale','Severity')">DSM-IV</a></li></ul><div class="DSM_clear"><img src="../../Style Library/DSM_Images/clear.gif" width="0" height="0" alt=""></div></div><div id="DSM_TabContent_Proposed"><p><font size="2"><b><span style="font-family:'arial', 'sans-serif'">Narcolepsy/Hypocretin Deficiency</span></b> </font></p>
<p align="right"><em>Updated May 1, 2012</em><span style="font-family:'arial', 'sans-serif'"><span><font size="2"></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoNormal"><span><span>A.<span style="font:7pt 'times new roman'">     </span></span></span><span>Recurrent periods of irrepressible need to sleep, lapses into sleep or naps occurring within the same day. These must have been occurring at least three times per week over the last 3 months (when individual is untreated).</span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoNormal"><span><span>B.<span style="font:7pt 'times new roman'">     </span></span></span><span>The presence of at least two of the following:</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><span><span><span style="font:7pt 'times new roman'">           </span>1.<span style="font:7pt 'times new roman'">     </span></span></span><span>Cataplexy defined as: (i) brief (seconds to minutes) episodes of sudden bilateral loss of muscle tone with maintained consciousness, precipitated by laughter or joking in individuals with long standing disease, or (ii) spontaneous grimaces or jaw opening episodes with tongue thrusting or a global hypotonia without any obvious emotional triggers in children and/or in individuals within 6 months of onset. These episodes must occur at least a few times per month (when the individual is untreated for this symptom).</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><span><span><span style="font:7pt 'times new roman'">           </span>2.<span style="font:7pt 'times new roman'">     </span></span></span><span>Hypocretin deficiency, as measured using cerebrospinal fluid hypocretin-1 immunoreactivity measurements (&lt;1/3 of values obtained in healthy subjects tested during the same assay, or ≤110 pg/ml). Low cerebrospinal fluid hypocretin-1 must not be observed in the context of acute brain injury, inflammation or infection.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><span><span><span style="font:7pt 'times new roman'">           </span>3.<span style="font:7pt 'times new roman'">     </span></span></span><span>Nocturnal sleep polysomnography showing <span>rapid eye movement (REM) </span>sleep latency less than or equal to 15 minutes, or a Multiple Sleep Latency Test showing a mean sleep latency less than or equal to 8 minutes and two or more sleep onset REM periods.</span></p>
<p class="MsoNormal" align="left"></font></span></span> </p></div><div id="DSM_TabContent_Rationale"><p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><span style="font-family:'arial', 'sans-serif'"><font size="2"><b><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></p>
<p class="MsoNormal" align="center"><b><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Rationale for the Proposed Changes to Narcolepsy/Hypocretin Deficiency</span></b></p></span></b>
<p class="MsoNormal" align="right"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Updated May 1, 2012</span></i></p>
<p class="MsoNormal"><u><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Summary</span></u><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">:<span>  </span>The Sleep Disorders Workgroup recommends the following:</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Replacing “narcolepsy” by “narcolepsy/hypocretin deficiency” </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Rewording criteria A “<span style="color:black">Irresistible attacks of refreshing sleep that occur daily over at</span></span></p>
<p style="text-autospace:" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">least 3 months” as “</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Recurrent periods of irrepressible need to sleep, lapses into sleep or naps occurring within the same day. These must have been occurring at least three times per week over the last 3 months (when individual is untreated).”</span></p>
<p style="text-autospace:" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">In the original classification, only one of two B criteria had to be met. In the revised classification, two of 3 B criteria have to be met.</span></p>
<p style="text-autospace:" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Rewording criteria B1 “<span style="color:black">cataplexy (i.e., brief episodes of sudden bilateral loss of muscle tone, most often in association with intense emotion)” as </span><span> </span>“Cataplexy defined as: (i) brief (seconds to minutes) episodes of sudden bilateral loss of muscle tone with maintained consciousness, precipitated by laughter or joking in individuals with long standing disease, or (ii) spontaneous grimaces or jaw opening episodes with tongue thrusting or a global hypotonia without any obvious emotional triggers in children and/or in individuals within 6 months of onset. These episodes must occur at least a few times per month (when the individual is untreated for this symptom).”</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Delete criteria B2:<span>  </span>“recurrent intrusions of elements of rapid eye movement (REM) sleep into the transition between sleep and wakefulness, as manifested by either hypnopompic or hypnagogic hallucinations or sleep paralysis at the beginning or end of sleep episodes”</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Insert new criteria B2: “Hypocretin deficiency, as measured using cerebrospinal fluid hypocretin-1 immunoreactivity measurements (&lt;1/3 of values obtained in healthy subjects tested during the same assay, or ≤110 pg/ml). Low cerebrospinal fluid hypocretin-1 must not be observed in the context of acute brain injury, inflammation or infection.”</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Insert new criteria B3 “Nocturnal sleep polysomnography showing rapid eye movement (REM) sleep latency less than or equal to 15 minutes, or a Multiple Sleep Latency Test showing a mean sleep latency less than or equal to 8 minutes and two or more sleep onset REM periods.”</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Delete Criteria C: <span style="color:black">The disturbance is not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or another general medical condition.”</span></span></p>
<p style="text-align:center" class="MsoNormal" align="center"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">____________________________</span></p>
<p style="text-align:center" class="MsoNormal" align="center"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><b><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Change #1.<span>  </span>Replace title of “narcolepsy” to “narcolepsy/hypocretin deficiency”</span></b></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Reasons for the change:</span></i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">The current diagnosis criteria are outdated and with time it became more evident that the only symptom that is specific for narcolepsy is cataplexy. Narcolepsy had been originally described with the presence of cataplexy</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Fromherz, 2004 #1614" href="#_enref_1"><span style="color:windowtext;text-decoration:none;text-underline:none">1</span></a>, <a title="Mignot, 2001 #1613" href="#_enref_2"><span style="color:windowtext;text-decoration:none;text-underline:none">2</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>In the late 1950s however, it was discovered that patients with narcolepsy also have a short REM sleep latency, a finding that led to using the Multiple Sleep Latency Test (MSLT) as a diagnostic test for narcolepsy (mean sleep latency ≤ 5 minutes and more recently ≤8 minutes with ≥2 occurrence of REM sleep in 4-5 naps as a positive test). The MSLT is a good test, with few false positives and few false negatives (~95% sensitivity, ~95% specificity) </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Aldrich, 1997 #55" href="#_enref_3"><span style="color:windowtext;text-decoration:none;text-underline:none">3</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>Unfortunately, as first noted by Chervin et al. true narcolepsy cases have been submerged by a large number of patients who complain of daytime sleepiness without a clear cause, and were not found to have sleep apnea</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Chervin, 2000 #78" href="#_enref_4"><span style="color:windowtext;text-decoration:none;text-underline:none">4</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>The high frequency of sleep apnea and polysomnography testing for this syndrome created a need to explain pathological sleepiness in patients without cataplexy and sleep apnea.<span>  </span>Studies in the general population have found that approximately 2-5% of subjects in the general population have a pathological MLST</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Singh, 2006 #1267" href="#_enref_5"><span style="color:windowtext;text-decoration:none;text-underline:none">5</span></a>, <a title="Mignot, 2006 #651" href="#_enref_6"><span style="color:windowtext;text-decoration:none;text-underline:none">6</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">, half of whom do not even complain of daytime sleepiness.</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Overtime, the original definition of narcolepsy, which implicated presence of cataplexy in the majority of cases (typically 80% in early cases series) expanded to include anyone with a positive MLST suggesting abnormally short REM sleep latency, expanding the notion of narcolepsy.<span>  </span>Sleep paralysis and hypnagogic hallucinations, accessory REM sleep related symptoms found in patients with narcolepsy became as important as cataplexy as symptoms defining abnormal REM sleep, following publications by Yoss and Daly</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Fromherz, 2004 #102" href="#_enref_7"><span style="color:windowtext;text-decoration:none;text-underline:none">7</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">, although these can frequently be found in other sleep pathologies or even in normal individuals</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Ohayon, 1996 #252" href="#_enref_8"><span style="color:windowtext;text-decoration:none;text-underline:none">8</span></a>, <a title="Ohayon, 1999 #253" href="#_enref_9"><span style="color:windowtext;text-decoration:none;text-underline:none">9</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>This evolution occurred based on a clinical need and in the absence of scientific data.<span>  </span>The definition of narcolepsy was slowly “expanded” to include all patients with cataplexy (A plus original B1) and an increasing number of patients with unexplained sleepiness and either an abnormal MSLT (in the original International classification of sleep disorders, ICSD1) or hynagogic hallucinations/sleep paralysis (criteria B2 of the original DSMIV).</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">In 2000, it was discovered that most cases with narcolepsy and cataplexy have hypocretin deficiency</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Nishino, 2000 #245" href="#_enref_10"><span style="color:windowtext;text-decoration:none;text-underline:none">10-12</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">. Animal models without hypocretin have narcolepsy, establishing causality </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Lin, 1999 #157" href="#_enref_13"><span style="color:windowtext;text-decoration:none;text-underline:none">13</span></a>, <a title="Chemelli, 1999 #400" href="#_enref_14"><span style="color:windowtext;text-decoration:none;text-underline:none">14</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">. <span> </span>More than 10 different groups from different countries across the world replicated this finding, demonstrating that almost all patients with cataplexy have low or undetectable levels of hypocretin-1 in the cerebrospinal fluid</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Hong, 2002 #130" href="#_enref_15"><span style="color:windowtext;text-decoration:none;text-underline:none">15-23</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>In contrast, only 5-30% (depending how carefully other causes of daytime sleepiness have been excluded) of cases without cataplexy were found to have low CSF hypocretin-1 (25-50% of cases with low CSF hypocretin and no cataplexy actually also develop cataplexy 1-40 years later after the beginning of sleepiness) </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Bourgin, 2008 #629" href="#_enref_24"><span style="color:windowtext;text-decoration:none;text-underline:none">24</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">This evolution was recognized by the ICSD2, second edition published in 2005 that separated narcolepsy with and without cataplexy as separate disease entities</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="AmericanAcademyofSleepMedicine, 2005 #1616" href="#_enref_25"><span style="color:windowtext;text-decoration:none;text-underline:none">25</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>Further, as a larger number of patients became aware of narcolepsy and cataplexy, and as the condition is treated by potentially addictive medications (amphetamine like compounds) for life, it was felt that objective confirmation either by measuring CSF hypocretin or by having a positive MSLT was strongly advised (but not mandated).</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">The new DSMV name “narcolepsy/hypocretin deficiency” now encompasses a real disease entity with a single etiology and a consistent set of symptoms.<span>  </span>As it is revised, it is more similar to ICSD2 criteria for narcolepsy/cataplexy and will be almost identical to ICSD3 proposed criteria for a similar entity (to be called Type I narcolepsy, as they found the term hypocretin deficiency “clumsy”).<span>  </span>We prefer hypocretin deficiency as it is more descriptive and already extensively used in the literature. <span> </span>Type 1 versus type 2 narcolepsy aims at mimicking the type 1 versus type 2 diabetes nomenclature, but in the case of diabetes mellitus, type 2 diabetes cases are insulin resistant, which is not known for hypocretin resistance in the proposed type 2 narcolepsy. </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Therapy is more codified for this biologically defined entity, which was previously “contaminated” by 5-50% (depending of the case series) of patients with other problems of multiple etiologies, previously called narcolepsy without cataplexy and already separated in the ICSD2 as narcolepsy without cataplexy.</span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt" lang="EN-CA">Evidence for the change:</span></i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt" lang="EN-CA"> </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">The proposed change is supported by strong scientific evidence (for details, see individual criteria changes):</span></p>
<ol style="margin-top:0in" type="a">
<li style="line-height:normal;margin-bottom:0pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">Narcolepsy with cataplexy is almost always caused by hypocretin deficiency.<span>  </span>Multiple studies across countries and ethnic groups have shown that 70-100% of cases with cataplexy have low CSF hypocretin-1 when this biochemical measure is assessed. In Mignot et al., </span><span style="font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Mignot, 2002 #197" href="#_enref_17"><span style="color:windowtext;text-decoration:none;text-underline:none">17</span></a>]</span></span><span style="font-family:'arial','sans-serif';font-size:10pt"> for example, data showed that “in cases with definite cataplexy, specificity (99%) and sensitivity (89%) for the CSF test was high”.<span>  </span>Similarly, Dauviliers et al., </span><span style="font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Dauvilliers, 2003 #83" href="#_enref_21"><span style="color:windowtext;text-decoration:none;text-underline:none">21</span></a>]</span></span><span style="font-family:'arial','sans-serif';font-size:10pt"> found “low CSF hypocretin-1 is highly specific (99.1%) and sensitive (88.5%) for narcolepsy with cataplexy”. </span></li></ol>
<p style="margin-left:0.5in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<ol style="margin-top:0in" type="a" start="2">
<li style="line-height:normal;margin-bottom:0pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">In contrast, 0-30% only of narcolepsy cases without cataplexy have normal CSF hypocretin-1, indicating that loss of hypocretin is not causally involved in producing symptoms in most of these cases.<span>  </span>Dauvilliers et al. </span><span style="font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Dauvilliers, 2003 #83" href="#_enref_21"><span style="color:windowtext;text-decoration:none;text-underline:none">21</span></a>]</span></span><span style="font-family:'arial','sans-serif';font-size:10pt"> for example found no subjects without cataplexy and low CSF hypocretin, Knudsen et al. </span><span style="font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Knudsen, 2010 #905" href="#_enref_23"><span style="color:windowtext;text-decoration:none;text-underline:none">23</span></a>]</span></span><span style="font-family:'arial','sans-serif';font-size:10pt"> found 21% and Mignot et al.</span><span style="font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Mignot, 2002 #197" href="#_enref_17"><span style="color:windowtext;text-decoration:none;text-underline:none">17</span></a>]</span></span><span style="font-family:'arial','sans-serif';font-size:10pt"> found 30%.<span>  </span></span></li></ol>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<ol style="margin-top:0in" type="a" start="3">
<li style="line-height:normal;margin-bottom:0pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">Symptoms such as sleep paralysis or hypnagogic hallucinations are frequent in the general population (4-6% for sleep paralysis, 40-6% for hypgnaogic hallucinations depending of how frequently these occur and how the questions are asked) </span><span style="font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Ohayon, 1996 #252" href="#_enref_8"><span style="color:windowtext;text-decoration:none;text-underline:none">8</span></a>, <a title="Ohayon, 1999 #253" href="#_enref_9"><span style="color:windowtext;text-decoration:none;text-underline:none">9</span></a>]</span></span><span style="font-family:'arial','sans-serif';font-size:10pt">, are increased by sleep deprivation, and are also significantly associated with anxiety and depression in population based studies</span><span style="font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Szklo-Coxe, 2007 #321" href="#_enref_26"><span style="color:windowtext;text-decoration:none;text-underline:none">26-28</span></a>]</span></span><span style="font-family:'arial','sans-serif';font-size:10pt">.<span>   </span>Although about half of narcoleptic patients with cataplexy </span><span style="font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Overeem, 2001 #263" href="#_enref_29"><span style="color:windowtext;text-decoration:none;text-underline:none">29</span></a>]</span></span><span style="font-family:'arial','sans-serif';font-size:10pt">or hypocretin deficiency </span><span style="font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Mignot, 2002 #197" href="#_enref_17"><span style="color:windowtext;text-decoration:none;text-underline:none">17</span></a>]</span></span><span style="font-family:'arial','sans-serif';font-size:10pt"> have these symptoms and that those can be a problem clinically, they are not useful diagnostically having poor specificity and poor sensitivity.</span></li></ol>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">The proposed change will increase etiological homogeneity for the condition based on new pathophysiological findings, the basis of all medical science.<span>  </span>All the findings above are undisputable and accepted by the scientific community and sleep clinicians.<span>  </span></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Integration with the International Classification of Sleep Disorders.</span></i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>  </span>These revised criteria have already been mostly integrated in the current International Classification of Sleep Disorders 2 (ICSD2) second edition in 2005, which has been in use for ~ 7 years.<span>  </span>The ICSD2 classification already distinguishes narcolepsy with and without cataplexy as two separate disease entities, thus the DSMV is mostly catching up with established textbook nosology knowledge.<span>  </span>Of note, the new ICSD3 classification, the next iteration of the ICSD currently under development will also use very similar diagnostic criteria for a similar disease entity, although the name is still debated. The name may indeed be called type I narcolepsy (instead of narolepsy/hypocretin deficiency), in reference to type I diabetes due to the autoimmune destruction of insulin producing cells and thus insulin deficiency. Whether or not the name is the same, the two classifications will essentially cover the same entity, with minor details (the exact definition of what constitutes cataplexy for diagnostic purposes)</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">evidence for the change:</span></i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>  </span>This is a simple clarification and an update. Cataplexy is both underdiagnosed and overdiagnosed thus the need to describe more exactly how it may manifest upfront in the criteria. Classically, cataplexy is indeed triggered by emotions but studies have shown the type of emotions is more important than the intensity </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Okun, 2002 #256" href="#_enref_33"><span style="color:windowtext;text-decoration:none;text-underline:none">33</span></a>, <a title="Anic-Labat, 1999 #59" href="#_enref_34"><span style="color:windowtext;text-decoration:none;text-underline:none">34</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>For example, fear, anxiety, or a sudden sound are not good triggers.<span>  </span>The most specific trigger that distinguish best true cataplexy in narcolepsy patients from other experiences reported by non narcoleptic subjects is joking thus it has been incorporated </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Okun, 2002 #256" href="#_enref_33"><span style="color:windowtext;text-decoration:none;text-underline:none">33-35</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>Laughter is also commonly involved, although it may be more culturally dependent as mirth is really what triggers cataplexy in the context of laughter</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Okun, 2002 #256" href="#_enref_33"><span style="color:windowtext;text-decoration:none;text-underline:none">33-35</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">. </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">In addition, cataplexy is almost always very brief and patients reporting feeling weak and having to rest for 30 minutes to several hours almost never have narcolepsy</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Okun, 2002 #256" href="#_enref_33"><span style="color:windowtext;text-decoration:none;text-underline:none">33</span></a>, <a title="Anic-Labat, 1999 #59" href="#_enref_34"><span style="color:windowtext;text-decoration:none;text-underline:none">34</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">. Less than 15% of over 400 patients report that their cataplexy attacks usually last longer than 2 minutes</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Okun, 2002 #256" href="#_enref_33"><span style="color:windowtext;text-decoration:none;text-underline:none">33</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">. Five-10% report having attacks 1 per year or less, less than 20% at least once per month.<span>   </span>For this reason, a few times per months when untreated was felt reasonable, while when treated it could become rare.</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Finally, as knowledge of the disorder has increased, more and more patients, notably young children are diagnosed very close to a rapid and catastrophic onset that can occur in a few weeks.<span>  </span>In these cases, cataplexy manifest often differently, by semiconstant, tic like partial hypotonia of the jaw with tongue opening or even a generalized weakness that does not have any clear trigger </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Plazzi, 2011 #41" href="#_enref_36"><span style="color:windowtext;text-decoration:none;text-underline:none">36-38</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>These cases, rarely seen before, evolve into the more classic form (with usual trigger) 6 month to 1 year later.<span>  </span></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span></span></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Thanks to improved treatment modalities (especially sodium oxybate), patients can now have months or even years without any cataplectic attacks.<span>  </span>For this reason, a caveat was added regarding low frequency in some successfully treated patients.<span>  </span></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">The definition of cataplexy proposed here is fairly similar to that currently underwork in the ICSD3 (not surprisingly since they started with our definition). In the ICSD3, cataplexy is defined as more than one episode of generally brief (&lt; 2 minutes), usually bilaterally<span>   </span>symmetric episodes of sudden loss of muscle tone with retained consciousness precipitated by strong emotions, usually positive, with almost always some episodes precipitated by emotions associated with laughter. The finding of transient reversible loss of deep tendon reflexes during an attack, while rare, is a strong diagnostic finding. In children (and rarely adults) cataplexy may present close to disease onset as facial (or generalized) hypotonia with droopy eyelids, mouth opening and protruded tongue or gait unsteadiness not clearly related to emotion. Facial and masticatory movements may occur. In children, anticipation of reward is a common precipitant. It is important to use child-appropriate contexts and language when trying to elicit a history of cataplexy in children. </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">In the DSM3 most of these details are in the text. </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span>Change #4 Delete criteria B2:<span>  </span>“recurrent intrusions of elements of rapid eye movement (REM) sleep into the transition between sleep and wakefulness, as manifested by either hypnopompic or hypnagogic hallucinations or sleep paralysis at the beginning or end of sleep episodes”</span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Reasons and evidence for the change: </span></i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Hypnopompic or hypnagogic hallucinations or sleep paralysis at the beginning or end of sleep episodes are neither sensitive nor specific for narcolepsy</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Ohayon, 1996 #252" href="#_enref_8"><span style="color:windowtext;text-decoration:none;text-underline:none">8</span></a>, <a title="Ohayon, 1999 #253" href="#_enref_9"><span style="color:windowtext;text-decoration:none;text-underline:none">9</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">, are increased by sleep deprivation, and are also significantly associated with anxiety and depression in population based studies</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Szklo-Coxe, 2007 #321" href="#_enref_26"><span style="color:windowtext;text-decoration:none;text-underline:none">26-28</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>   </span>Although about half of narcoleptic patients with cataplexy </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Overeem, 2001 #263" href="#_enref_29"><span style="color:windowtext;text-decoration:none;text-underline:none">29</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">or hypocretin deficiency </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Mignot, 2002 #197" href="#_enref_17"><span style="color:windowtext;text-decoration:none;text-underline:none">17</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> have these symptoms and that those can be a problem clinically, they are not useful diagnostically having poor specificity and poor sensitivity.</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Evidence for change: </span></i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt" lang="EN-CA">The proposed change is supported by evidence based </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span> </p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Change #5. Insert new criteria B2: “Hypocretin deficiency, as measured using cerebrospinal fluid hypocretin-1 immunoreactivity measurements (&lt;1/3 of values obtained in healthy subjects tested during the same assay, or ≤110 pg/ml). Low cerebrospinal fluid hypocretin-1 must not be observed in the context of acute brain injury, inflammation or infection.”</span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Reasons for the change: </span></i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span> </span>The biological basis of the disorder has been established.<span>  </span>This criteria was already included in the ICSD2 as diagnostic for narcolepsy. It will also be in the ICSD3 as is.<span>  </span>The entire disorder is redefined based on pathophysiology and this particular biological test (see name change).<span>  </span>Even if not advised/necessary in clear cases, this test is helpful in clarifying diagnosis of some complex cases, for example subjects where cataplexy is of psychogenic origin, when there is confounding psychiatric or other comorbidities, or when sleep tests cannot be performed because the patient is taking medications that can change REM sleep occurrence (most psychotropic compounds) and cannot be easily stopped</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Mignot, 2003 #190" href="#_enref_39"><span style="color:windowtext;text-decoration:none;text-underline:none">39</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.</span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Evidence for the change:</span></i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> The finding of low CSF hypocretin-1 in narcolepsy has been replicated by more than ten laboratories across all continents except Africa Hong, 2002 #130}</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Kanbayashi, 2002 #141" href="#_enref_16"><span style="color:windowtext;text-decoration:none;text-underline:none">16-23</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>The particular threshold of 110 pg/ml or 1/3 of mean control values has been established by Quantitative Receiving Operating Curves in comparisons to healthy controls, cases with other sleep disorders (including narcolepsy without cataplexy, hypersomnia, insomnia), and samples drawn from patients with various acute or chronic neurological conditions </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Mignot, 2002 #197" href="#_enref_17"><span style="color:windowtext;text-decoration:none;text-underline:none">17</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>As part of this extensive survey, it was found that normal subjects essentially never have low CSF hypocretin levels, but that some patients with severe acute neurological disorders (acute menigintis, severe head trauma, etc, generally comatose) can have decreased CSF hypocretin, a finding that is reversible when/if the condition improves. For this reason a caveat regarding interpretation of this test in severe acute neurological disorder was added </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Mignot, 2002 #197" href="#_enref_17"><span style="color:windowtext;text-decoration:none;text-underline:none">17</span></a>, <a title="Bourgin, 2008 #629" href="#_enref_24"><span style="color:windowtext;text-decoration:none;text-underline:none">24</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Change #6. Insert new criteria B3 “Nocturnal sleep polysomnography showing rapid eye movement (REM) sleep latency less than or equal to 15 minutes, or a Multiple Sleep Latency Test showing a mean sleep latency less than or equal to 8 minutes and two or more sleep onset REM periods.”</span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Reasons for the change:</span></i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> Past criteria were entirely subjective and did not correspond with clinical practice and insurance policy that typically mandates a positive sleep test as an objective finding, generally a Multiple Sleep Latency Test (MSLT) showing a mean sleep latency less than or equal to 8 minutes and two or more sleep onset REM periods.<span>  </span>This is important to avoid prescription of amphetamine like compounds broadly without objective evidence (sleep test or CSF hypocretin).<span>  </span>More recently, studies have shown that the observation of a short REM latency during a nocturnal sleep study is more specific (~99%) but less sensitive (~50%) than a positive MSLT (SE~95%, SP~ 95%) (unpublished data submitted to JAMA).<span>  </span>Based on this recent evidence, sleep test criteria consistent with narcolepsy can be either a SOREMP at night (rapid eye movement (REM) sleep latency less than or equal to 15 minutes) or a positive MSLT.<span>  </span>The advantage of this improved criteria that will also be incorporated in the revised ICSD3, is that if the sleep study performed the night before the MSLT shows a SOREMP (50%) of the cases, the daytime MSLT test can be cancelled, saving time and money without increasing false positive significantly.</span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"></span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Evidence for the change:</span></i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> Specificity and sensitivity for the MSLT for narcolepsy –cataplexy have all shown ~95% sensitivity and specificity either when cataplexy is used as a gold standard or when CSF hypocretin has been measured </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Aldrich, 1997 #55" href="#_enref_3"><span style="color:windowtext;text-decoration:none;text-underline:none">3</span></a>, <a title="Mignot, 2002 #197" href="#_enref_17"><span style="color:windowtext;text-decoration:none;text-underline:none">17</span></a>, <a title="Moscovitch, 1993 #219" href="#_enref_40"><span style="color:windowtext;text-decoration:none;text-underline:none">40</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>It is a good test to objectively confirm narcolepsy/hypocretin deficiency when cataplexy is present.<span>  </span>Rationale for the addition of the short REM latency data during a nocturnal sleep study is described in the publication submitted to JAMA.<i></i></span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></i></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Change #7. Delete Criteria C: The disturbance is not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or another general medical condition.”</span></p>
<p class="MsoNormal"><i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">Reason and evidence for the change:</span></i><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>  </span>Hypocretin deficiency and cataplexy cannot be caused by substance abuse, drugs, psychological conditions, or general medical or neurological conditions</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Mignot, 2002 #197" href="#_enref_17"><span style="color:windowtext;text-decoration:none;text-underline:none">17</span></a>, <a title="Bourgin, 2008 #629" href="#_enref_24"><span style="color:windowtext;text-decoration:none;text-underline:none">24</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>A few rare syndromes, tumoral/surgical lesions of the hypothalamus are associated with genuine hypocretin cell loss and deficiency, but in these cases the appellation narcolepsy/hypocretin deficiency is still valid</span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Mignot, 2002 #197" href="#_enref_17"><span style="color:windowtext;text-decoration:none;text-underline:none">17</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>Further, at time, it is difficult to know if the association with another disorder such as a tumor is not a chance association between an autoimmune loss of hypocretin (the major cause of hypocretin deficiency) and another condition that is a mere precipitating factor, as alreasy pointed out before the discovery of hypocretin deficiency as the cause of narcolepsy </span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"><span>[<a title="Aldrich, 1989 #56" href="#_enref_41"><span style="color:windowtext;text-decoration:none;text-underline:none">41</span></a>]</span></span><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>The ICSD3 will also remove a similar statement contained in the ICSD2. </span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="text-autospace:" class="MsoNormal"><b><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">References:</span></b></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"><a name="_ENREF_1"><span>[1]<span>        </span>Fromherz S, Mignot E: Narcolepsy research: past, present, and future perspectives. Archives italiennes de biologie 2004;142:479.</span></a><span></span></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_2"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[2]<span>        </span>Mignot E: A hundred years of narcolepsy research. Archives italiennes de biologie 2001;139:207.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_3"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[3]<span>        </span>Aldrich MS, Chervin RD, Malow BA: Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 1997;20:620.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_4"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[4]<span>        </span>Chervin RD, Aldrich MS: Sleep onset REM periods during multiple sleep latency tests in patients evaluated for sleep apnea. Am J Respir Crit Care Med 2000;161:426.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_5"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[5]<span>        </span>Singh M, Drake CL, Roth T: The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep 2006;29:890.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_6"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[6]<span>        </span>Mignot E, Lin L, Finn L, Lopes C, Pluff K, Sundstrom MLet al. : Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain : a journal of neurology 2006;129:1609.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_7"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[7]<span>        </span>Fromherz S, Mignot E: Narcolepsy research: past, present, and future perspectives. Arch Ital Biol 2004;142:479.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_8"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[8]<span>        </span>Ohayon MM, Priest RG, Caulet M, Guilleminault C: Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry 1996;169:459.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_9"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[9]<span>        </span>Ohayon MM, Zulley J, Guilleminault C, Smirne S: Prevalence and pathologic associations of sleep paralysis in the general population. Neurology 1999;52:1194.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_10"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[10]<span>      </span>Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E: Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_11"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[11]<span>      </span>Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Yet al. : A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_12"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[12]<span>      </span>Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich Met al. : Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_13"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[13]<span>      </span>Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin Xet al. : The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_14"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[14]<span>      </span>Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee Cet al. : Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_15"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[15]<span>      </span>Hong SC, Leen K, Park SA, Han JH, Lee SP, Lin Let al. : HLA and hypocretin studies in Korean patients with narcolepsy. Sleep 2002;25:440.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_16"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[16]<span>      </span>Kanbayashi T, Inoue Y, Chiba S, Aizawa R, Saito Y, Tsukamoto Het al. : CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res 2002;11:91.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_17"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[17]<span>      </span>Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem Set al. : The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_18"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[18]<span>      </span>Dalal MA, Schuld A, Haack M, Uhr M, Geisler P, Eisensehr Iet al. : Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology 2001;56:1749.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_19"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[19]<span>      </span>Heier MS, Evsiukova T, Vilming S, Gjerstad MD, Schrader H, Gautvik K: CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway. Sleep 2007;30:969.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_20"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[20]<span>      </span>Krahn LE, Pankratz VS, Oliver L, Boeve BF, Silber MH: Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep 2002;25:733.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_21"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[21]<span>      </span>Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, Lecendreux Met al. : CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 2003;74:1667.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_22"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[22]<span>      </span>Bassetti C, Gugger M, Bischof M, Mathis J, Sturzenegger C, Werth Eet al. : The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep medicine 2003;4:7.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_23"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[23]<span>      </span>Knudsen S, Jennum PJ, Alving J, Sheikh SP, Gammeltoft S: Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population. Sleep 2010;33:169.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_24"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[24]<span>      </span>Bourgin P, Zeitzer JM, Mignot E: CSF hypocretin-1 assessment in sleep and neurological disorders. Lancet neurology 2008;7:649.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_25"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[25]<span>      </span>AmericanAcademyofSleepMedicine: The International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd ed. Westchester, IL: American Academy of sleep Medicine; 2005.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_26"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[26]<span>      </span>Szklo-Coxe M, Young T, Finn L, Mignot E: Sleep paralysis, hypnagogic hallucinations, cataplexy: Narcolepsy spectrum and aternate etiology. In Bassetti C, Billiard M, Mignot E (eds): Narcolepsy and Hypersomnia. New York, Marcel Dekker/Taylor & Francis Health Sciences, 2007, p 133.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_27"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[27]<span>      </span>Szklo-Coxe M, Young T, Finn L, Mignot E: Depression: relationships to sleep paralysis and other sleep disturbances in a community sample. Journal of sleep research 2007;16:297.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_28"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[28]<span>      </span>Munezawa T, Kaneita Y, Osaki Y, Kanda H, Ohtsu T, Suzuki Het al. : Nightmare and sleep paralysis among Japanese adolescents: a nationwide representative survey. Sleep medicine 2011;12:56.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_29"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[29]<span>      </span>Overeem S, Mignot E, van Dijk JG, Lammers GJ: Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001;18:78.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_30"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[30]<span>      </span>Ohayon MM, Dauvilliers Y, Reynolds CF, 3rd: Operational Definitions and Algorithms for Excessive Sleepiness in the General Population: Implications for DSM-5 Nosology. Archives of general psychiatry 2012;69:71.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_31"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[31]<span>      </span>Ohayon MM: Determining the level of sleepiness in the American population and its correlates. Journal of Psychiatric Research 2012;in press:1.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_32"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[32]<span>      </span>Ohayon MM, Priest RG, Zulley J, Smirne S, Paiva T: Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 2002;58:1826.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_33"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[33]<span>      </span>Okun ML, Lin L, Pelin Z, Hong S, Mignot E: Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep 2002;25:27.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_34"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[34]<span>      </span>Anic-Labat S, Guilleminault C, Kraemer HC, Meehan J, Arrigoni J, Mignot E: Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep 1999;22:77.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_35"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[35]<span>      </span>Overeem S, van Nues SJ, van der Zande WL, Donjacour CE, van Mierlo P, Lammers GJ: The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep medicine 2011;12:12.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_36"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[36]<span>      </span>Plazzi G, Pizza F, Palaia V, Franceschini C, Poli F, Moghadam KVet al. : Complex movement disorders in childhood narcolepsy with cataplexy at disease onset. . Brain 2011.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_37"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[37]<span>      </span>Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E: Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep 2010;33:1457.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_38"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[38]<span>      </span>Serra L, Montagna P, Mignot E, Lugaresi E, Plazzi G: Cataplexy features in childhood narcolepsy. Movement disorders : official journal of the Movement Disorder Society 2008;23:858.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_39"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[39]<span>      </span>Mignot E, Chen W, Black J: On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy. Sleep 2003;26:646.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_40"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[40]<span>      </span>Moscovitch A, Partinen M, Guilleminault C: The positive diagnosis of narcolepsy and narcolepsy's borderland. Neurology 1993;43:55.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"><a name="_ENREF_41"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt">[41]<span>      </span>Aldrich MS, Naylor MW: Narcolepsy associated with lesions of the diencephalon. Neurology 1989;39:1505.</span></a><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"></span></p>
<p class="MsoNormal"><span style="line-height:115%;font-family:'arial','sans-serif';color:black;font-size:10pt"> </span></p>
<p style="text-indent:-0.5in;margin-left:0.5in" class="MsoNormal"></font></span><span style="font-family:'arial', 'sans-serif'"></p>
<p class="MsoNormal"><span style="font-family:'arial', 'sans-serif'"><font size="2"></font></span></span> </p></div><div id="DSM_TabContent_Severity"><p class="MsoNormal"><span style="font-family:'arial','sans-serif'"><font size="2">1. Stanford Sleep Inventory (1)</font></span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif'"><font size="2">2. Epworth sleepiness Scale</font></span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif'"><font size="2">3. Multiple Sleep Latency Test</font></span></p>
<p class="MsoNormal"><span style="font-family:'arial','sans-serif'"><font size="2">4. Maintenance of Wakefulness test</font></span></p></div><div id="DSM_TabContent_DSM-IV"><span style="font-family:'arial', 'sans-serif';color:black"><font size="2"><strong>Narcolepsy</strong></font></span> 
<p class="MsoNormal"><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">A. Irresistible attacks of refreshing sleep that occur daily over at </font></span><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">least 3 months.</font></span></p>
<p class="MsoNormal"><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">B. The presence of one or both of the following:</font></span></p>
<p class="MsoNormal"><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">(1) cataplexy (i.e., brief episodes of sudden bilateral loss of </font></span><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">muscle tone, most often in association with intense emotion)</font></span></p>
<p class="MsoNormal"><span style="font-family:'arial', 'sans-serif';color:black"></span><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">(2) recurrent intrusions of elements of rapid eye movement </font></span><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">(REM) sleep into the transition between sleep and wakefulness, </font></span><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">as manifested by either hypnopompic or hypnagogic </font></span><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">hallucinations or sleep paralysis at the beginning or </font></span><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">end of sleep episodes</font></span></p>
<p class="MsoNormal"><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">C. The disturbance is not due to the direct physiological effects </font></span><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">of a substance (e.g., a drug of abuse, a medication) or another </font></span><span style="font-family:'arial', 'sans-serif';color:black"><font size="2">general medical condition.</font></span></p></div></td></tr></table></td></tr></table><table cellspacing="0" cellpadding="4" border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr></tr></table></div></td>
			</tr>
		</table><div class="ms-PartSpacingVertical"></div></td>
	</tr><tr>
		<td id="MSOZoneCell_WebPartWPQ4" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="f02ada8a-2400-4fe7-8d10-03411362e842" haspers="false" id="WebPartWPQ4" width="100%" class="ms-WPBody" allowdelete="false" style=""><script type="text/javascript">
$(document).ready(function() {
  TabClick('Proposed','Rationale','Severity','DSM-IV');
});
</script></div></td>
			</tr>
		</table></td>
	</tr>
</table>								
	</div>
	<div id="DSM_RightCol">
		<div id="DSM_int_topRight">	
		</div>
		<div id="DSM_int_btmRight">
			<div id="ctl00_PlaceHolderMain_ctl00__ControlWrapper_RichHtmlField" style="display:inline"></div>						
			<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ3" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="3cf5e074-39b0-425f-92e8-f3c760a6ce71" haspers="false" id="WebPartWPQ3" width="100%" allowdelete="false" allowexport="false" style=""><table width="100%" cellspacing="0" cellpadding="0" border="0"><script>
ctx = new ContextInfo();
ctx.listBaseType = 0;
ctx.listTemplate = 103;
ctx.listName = "{59E5C57E-4B33-4F74-B28B-5BDB9754C4FB}";
ctx.view = "{3CF5E074-39B0-425F-92E8-F3C760A6CE71}";
ctx.listUrlDir = "\u002fproposedrevision\u002fLists\u002fRelated\u002520Links";
ctx.HttpPath = "\u002fproposedrevision\u002f_vti_bin\u002fowssvr.dll?CS=65001";
ctx.HttpRoot = "https:\u002f\u002f\u002fweb\u002f20121022212841\u002fhttp:\u002f\u002fwww.dsm5.org\u002fproposedrevision";
ctx.imagesPath = "\u002f_layouts\u002fimages\u002f";
ctx.PortalUrl = "";
ctx.SendToLocationName = "";
ctx.SendToLocationUrl = "";
ctx.RecycleBinEnabled = -1;
ctx.OfficialFileName = "";
ctx.WriteSecurity = "1";
ctx.SiteTitle = "Proposed Revisions";
ctx.ListTitle = "Related Links";
if (ctx.PortalUrl == "") ctx.PortalUrl = null;
ctx.displayFormUrl = "\u002fproposedrevision\u002fLists\u002fRelated\u002520Links\u002fDispForm.aspx";
ctx.editFormUrl = "\u002fproposedrevision\u002fLists\u002fRelated\u002520Links\u002fEditForm.aspx";
ctx.isWebEditorPreview = 0;
ctx.ctxId = 1;
g_ViewIdToViewCounterMap[ "{3CF5E074-39B0-425F-92E8-F3C760A6CE71}" ]= 1;
ctx.CurrentUserId = -1;
ctx1 = ctx;
</script><tr><td><table id="{59E5C57E-4B33-4F74-B28B-5BDB9754C4FB}-{3CF5E074-39B0-425F-92E8-F3C760A6CE71}" summary="Related Links" o:webquerysourcehref="http://www.dsm5.org/proposedrevision/_vti_bin/owssvr.dll?CS=65001&amp;XMLDATA=1&amp;RowLimit=0&amp;List={59E5C57E-4B33-4F74-B28B-5BDB9754C4FB}&amp;View={3CF5E074-39B0-425F-92E8-F3C760A6CE71}" class="ms-summarycustombody" style="margin-bottom: 5px;" cellpadding="0" cellspacing="0" border="0">
                        <tr>
                            <td style="padding-bottom: 5px" class="ms-vb"><img src="../../_layouts/images/square.gif" alt="">&nbsp;</td>
                            <td style="padding-bottom: 5px;padding-left: 5px;" class="ms-vb">
                        <a onfocus="OnLink(this)" href="http://www.psych.org/">American Psychiatric Association</a>
                            </td>
                        </tr>
                        <tr>
                            <td style="padding-bottom: 5px" class="ms-vb"><img src="../../_layouts/images/square.gif" alt="">&nbsp;</td>
                            <td style="padding-bottom: 5px;padding-left: 5px;" class="ms-vb">
                        <a onfocus="OnLink(this)" href="../../proposedrevision/Pages/proposed-dsm5-organizational-structure-and-disorder-names.html">Proposed DSM-5 Organizational Structure</a>
                            </td>
                        </tr>
                        <tr>
                            <td style="padding-bottom: 5px" class="ms-vb"><img src="../../_layouts/images/square.gif" alt="">&nbsp;</td>
                            <td style="padding-bottom: 5px;padding-left: 5px;" class="ms-vb">
                        <a onfocus="OnLink(this)" href="../../Pages/RecentUpdates.html">Recent Updates to Proposed Revisions for DSM-5</a>
                            </td>
                        </tr>
                    </table></td></tr></table><table id="ECBItems" style="display:none" height="0" width="0"><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XsnLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xsn</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.2</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.3</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.4</td><td>255</td></tr><tr><td>View in Web Browser</td><td>/_layouts/images/ichtmxls.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&DefaultItemOpen;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsx</td><td>255</td></tr><tr><td>View in Web Browser</td><td>/_layouts/images/ichtmxls.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&DefaultItemOpen;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsb</td><td>255</td></tr><tr><td>Snapshot in Excel</td><td>/_layouts/images/ewr134.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&Snapshot;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsx</td><td>256</td></tr><tr><td>Snapshot in Excel</td><td>/_layouts/images/ewr134.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&Snapshot;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsb</td><td>256</td></tr></table></div></td>
			</tr>
		</table></td>
	</tr>
</table>						
		</div>						
	</div>	
	<div class="DSM_clear"><img src="../../Style Library/DSM_Images/clear.gif" width="1" height="1" alt=""/></div>	
<!---- end MAIN CONTENT AREA ---->
			</div>
			<div id="DSM_Footer">
				<p class="DSM_Tagline">Representing 36,000 physician leaders in mental health.</p>
				<p>© <strong>2012 American Psychiatric Association.</strong> All Rights Reserved.<br/>
				Use of all Materials on this Website is subject to the <a href="../../Pages/PermissionsPolicy.html">APA Permissions Policy</a> and <a href="../../Pages/TermsandConditionsofUse.html">Terms and Conditions of Use.</a><br/>
				<br/>  
				1000 Wilson Boulevard, Suite 1825, Arlington, Va. 22209-3901<br/>
				phone: 703-907-7300 <a href="mailto:apa@psych.org?subject=DSM5:">email: apa@psych.org</a></p>
				<div class="DSM_SocialLinks">
	 				<table>
	 					<tr>
	 						<td>Find us on:</td>
							<td><a href="http://www.facebook.com/pages/DSM-5-Diagnostic-and-Statistical-Manual-of-Mental-Disorders/260197062886" target="_blank"><img src="../../Style Library/DSM_Images/facebook.gif" width="58" height="15" alt="Find us on Facebook"/></a></td>
							<td><a href="http://twitter.com/dsm5" target="_blank"><img src="../../Style Library/DSM_Images/twitter.jpg" width="60" height="20" alt="Find us on Twitter"/></a></td>
						</tr>
	 				</table>
				</div>
				<p><a href="../../pages/Contactus.html">Contact Us For Help</a></p>
			</div>		
		</div>
<!-- end MAIN LAYOUT -->
<!-- begin EDITOR POSITIONING DIV -->
	<div id="ctl00_MSO_ContentDiv" class="SP_editorPosition">&nbsp;</div>
<!-- end EDITOR POSITIONING DIV -->
<!-- begin HIDDEN MASTER PAGE ELEMENTS -->
	<div style="display:none">
			<div class="breadcrumb">
				<span id="ctl00_PlaceHolderTitleBreadcrumb_siteMapPath"><a href="#ctl00_PlaceHolderTitleBreadcrumb_siteMapPath_SkipLink"><img alt="Skip Navigation Links" height="0" width="0" src="../../WebResource.axd_d_nmHMzpcb8opA4_TBGiLLxg2_t_633965588901821931.jpg" border="0"/></a><span><a class="ms-sitemapdirectional" href="/">Home</a></span><span> &gt; </span><span><a title="DSM-5 Proposed Revisions" class="ms-sitemapdirectional" href="../../proposedrevision/Pages/Default.html">Proposed Revisions</a></span><span> &gt; </span><span class="breadcrumbCurrent">Proposed Revision</span><a id="ctl00_PlaceHolderTitleBreadcrumb_siteMapPath_SkipLink"></a></span>
			</div>
	</div>
<!-- end HIDDEN MASTER PAGE ELEMENTS -->
<script type="text/javascript">
//<![CDATA[
var __wpmExportWarning='This Web Part Page has been personalized. As a result, one or more Web Part properties may contain confidential information. Make sure the properties contain information that is safe for others to read. After exporting this Web Part, view properties in the Web Part description file (.WebPart) by using a text editor such as Microsoft Notepad.';var __wpmCloseProviderWarning='You are about to close this Web Part.  It is currently providing data to other Web Parts, and these connections will be deleted if this Web Part is closed.  To close this Web Part, click OK.  To keep this Web Part, click Cancel.';var __wpmDeleteWarning='You are about to permanently delete this Web Part.  Are you sure you want to do this?  To delete this Web Part, click OK.  To keep this Web Part, click Cancel.';var zz1_TopNavigationMenu_Data = new Object();
zz1_TopNavigationMenu_Data.disappearAfter = 500;
zz1_TopNavigationMenu_Data.horizontalOffset = 0;
zz1_TopNavigationMenu_Data.verticalOffset = 0;
zz1_TopNavigationMenu_Data.hoverClass = 'DSM_dynamicNavHover';
if (typeof(overrideMenu_HoverStatic) == 'function' && typeof(Menu_HoverStatic) == 'function')
{
_spBodyOnLoadFunctionNames.push('enableFlyoutsAfterDelay');
Menu_HoverStatic = overrideMenu_HoverStatic;
}
var flyoutsAllowed = false;
function enableFlyoutsAfterDelay()
{
setTimeout('flyoutsAllowed = true;', 50);
}
function overrideMenu_HoverStatic(item)
{
if (!flyoutsAllowed || (document.readyState != null && document.readyState != 'complete'))
{
setTimeout(delayMenu_HoverStatic(item), 50);
}
else
{
// this code is the default ASP.NET implementation of Menu_HoverStatic
var node = Menu_HoverRoot(item);
var data = Menu_GetData(item);
if (!data) return;
__disappearAfter = data.disappearAfter;
Menu_Expand(node, data.horizontalOffset, data.verticalOffset);
}
}
function delayMenu_HoverStatic(item)
{
return (function()
{
overrideMenu_HoverStatic(item);
});
}
//]]>
</script>
</form>
  <!-- Google Code -->
  <script type="text/javascript">
  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-16139255-17']);
  _gaq.push(['_setDomainName', '.dsm5.org']);
  _gaq.push(['_trackPageview']);
  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + 
'.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();
</script>
</body>
</html>